Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture.
Hiligsmann, M.; Williams, S.A.; Fitzpatrick, L.A. et al.
2018In Osteoporosis International, 29 S1, p. 302
Peer Reviewed verified by ORBi
 

Files


Full Text
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture..pdf
Publisher postprint (650.29 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Hiligsmann, M.
Williams, S.A.
Fitzpatrick, L.A.
Silverman, S.
Weiss, R.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture.
Publication date :
April 2018
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
Cracovie, Poland
Event date :
du 19 au 22 avril 2018
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer, Germany
Volume :
29 S1
Pages :
302
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 16 May 2018

Statistics


Number of views
97 (2 by ULiège)
Number of downloads
6 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi